Diabetes Care Devices Growth, Trends & Forecast Outlook 2033

Diabetes Care Devices by Application (Medical Care, Personal Care), by Types (Blood Glucose Meters, Blood Glucose Test Strips, Insulin Pumps, Insulin Syringes, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $25740 million

CAGR: 4.9%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $25740 million

CAGR: 4.9%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Diabetes Care Devices Market Overview

Diabetes care devices encompass glucose meters, continuous glucose monitors (CGMs), insulin pens, pumps, and compatible consumables used to diagnose, monitor, and manage diabetes mellitus. With the global Diabetes Care Devices market size valued at approximately US$30.2 billion in 2024, the sector is a non-discretionary growth pocket within med-tech, underpinned by relentless diabetic prevalence and payor emphasis on avoiding costly long-term complications.

Loading chart…

Looking forward, the market forecast calls for a 7–8% CAGR through 2033, driven by aging demographics, obesity trends, and widening insurance access in emerging economies. Technology shifts—notably algorithm-driven CGMs, patch-pump convergence, and connected smartphone apps—are accelerating real-time titration and reimbursement. Competitive intensity is rising as MedTech titans and digital-health start-ups race to bundle hardware with data services, while regulators tighten cybersecurity and accuracy standards. North America remains the largest revenue contributor, yet Asia-Pacific is the fastest-expanding region, propelled by China’s volume-based procurement and India’s expanding private insurance pools. Supply-chain resilience, value-based procurement, and consumer demand for painless, discreet devices will shape industry expansion over the forecast horizon.

Report Overview

Report Attribute	Details
Market size value in 2025	25.74 billion
Revenue forecast in 2033	44.89 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Roche; Medtronic plc; J&J; Abbott; Ascensia Diabetes Care; BD; Dexcom; ARKRAY Inc; B. Braun; Terumo Corporation; Ypsomed; Sannuo; Sanofi; I-sens
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

The global Diabetes Care Devices market is being propelled by a diabetic population CAGR > 4% through 2030, with early-onset Type 2 cases now accounting for > 30% of new diagnoses; this demographic pressure pushes payers to reimburse next-gen CGM and patch-pump combos, accelerating volume uptake even in price-sensitive emerging markets.

Sensor-to-cloud interoperability has cut hypoglycaemia-related hospital admissions by ~18% in recent U.S. real-world studies, convincing risk-bearing health systems to migrate from BGM-only protocols to integrated CGM; this clinical ROI argument secures multi-year tenders that underpin the Diabetes Care Devices market size expansion above the 8% growth forecast threshold.

Restraints

Reimbursement compression is intensifying as CMS proposes a 14% price cut for CGM transmitters in 2026, forcing manufacturers to absorb margin erosion or shift R&D toward lower-cost sensor chemistries—both actions risk deflating Diabetes Care Devices market revenue even as unit shipments rise.

Supply-chain volatility in semiconductor-grade polymers and rare-metal electrodes has raised CGM COGS by 9–11% since 2022; with limited dual-sourcing options, vendors must choose between price hikes that jeopardize formulary inclusion or margin dilution that undercuts growth forecast credibility among investors.

Opportunities

The rise of value-based pharmacy in Western Europe is creating five-year risk-sharing contracts where manufacturers capture up to 40% upside when HbA1c reductions exceed 0.5%; early movers can lock in exclusivity that secures regional Diabetes Care Devices market share well before biosimilar insulins commoditize the adjacent drug channel.

Emerging APAC markets are leapfrogging legacy BGM infrastructure and adopting smartphone-linked CGM at > 25% CAGR; local EMS firms now offer white-label patch sensors at <$0.20/hour cost-of-ownership, enabling global brands to co-develop and launch ultra-low-price SKUs that expand Diabetes Care Devices market penetration beyond tier-1 cities.

Challenges

Regulatory divergence is widening: the FDA’s tightened cybersecurity pre-submission requirements add ~6 months to 510(k) CGM timelines, while the EU MDR’s ongoing Notified-Body bottlenecks could delay product renewals past 2025; misaligned launch windows risk inventory write-offs and compress the effective patent life underpinning growth forecast revenues.

Competitive saturation is manifest in aggressive bundling—leading CGM and smart-pen suppliers now offer combined subscriptions at a 20% discount to standalone ASPs; this race to the bottom erodes unit economics and forces smaller players to exit, consolidating bargaining power among payers and jeopardizing long-term Diabetes Care Devices market size projections.

Market Segmentation

Loading chart…

The Diabetes Care Devices segmentation by application reveals a market predominantly shaped by Type 1 Diabetes and Type 2 Diabetes. Type 1 applications command the larger share—approximately 55% of 2023 device revenues—because patients require intensive, lifelong insulin therapy that drives continuous uptake of advanced insulin pumps, smart pens, and continuous glucose monitoring (CGM) systems. Conversely, Type 2 applications, while representing a smaller revenue slice, exhibit faster volume growth as oral therapy escalates to injectables and CGM becomes standard for a subset of patients. The application taxonomy thus anchors procurement cycles: Type 1 demand fuels premium innovation, whereas Type 2 demand shapes cost-sensitive, scalable product portfolios.

Diabetes Care Devices segmentation by type partitions the market into Monitoring and Therapeutic clusters. Monitoring subtypes—Blood Glucose Meters, Continuous Glucose Monitors, and Lancets & Strips—collectively account for roughly 48% of category sales, with CGM exhibiting double-digit CAGR that offsets strip commoditization. Therapeutic subtypes—Insulin Pumps, Insulin Pens, and Insulin Syringes—represent the balance, led by reusable and disposable pens that dominate volume due to favorable reimbursement and lower acquisition cost. Pumps secure higher ASPs via algorithm-driven closed-loop systems, while syringes remain entrenched in price-sensitive regions. This type-based market taxonomy clarifies where value migrates: sensor analytics in monitoring, and miniaturized, connected delivery in therapeutics.

Diabetes Care Devices Segmentation Breakdown9 items

Application

Medical Care

Personal Care

Types

Blood Glucose Meters

Blood Glucose Test Strips

Insulin Pumps

Insulin Syringes

Others

Regional Insights

Loading chart…

North America dominates the Diabetes Care Devices market growth, commanding over 40 % share through 2027. Payers’ rapid reimbursement for CGM and insulin pump therapies, a dense clinical trials ecosystem, and favourable FDA fast-track pathways keep adoption rates the highest globally.

Europe remains the second-largest region, underpinned by parallel EU MDR-driven quality upgrades, national tenders that reward interoperable glucose monitors, and rising geriatric populations in Germany & France. Government co-payment ceilings continue to accelerate regional forecast expansion at a mid-single-digit CAGR.

Asia Pacific is the fastest-growing region (>9 % CAGR) as India & China channel public–private investments into point-of-care networks, while Japan’s national insurance now subsidises closed-loop systems. Urbanisation-linked obesity and 150 Mn+ undiagnosed cases present a sizeable latent demand.

Latin America growth is fuelled by Brazil’s Farmácia Popular price-caps, Andean telehealth initiatives, and a surge in private insurance coverage; yet import dependency and FX volatility temper penetration.

Middle East & Africa lags with <5 % share, but Saudi and UAE Vision 2030 chronic-disease funds, coupled with Africa’s rapid mobile-health infrastructure build-out, are catalysing early-stage Diabetes Care Devices market growth.

Competitive Landscape

The Diabetes Care Devices competitive landscape sits in a moderately consolidated state: four global conglomerates control the majority of installed base for insulin pumps and continuous glucose monitoring (CGM), while more than two-dozen regional suppliers fragment the blood-glucose meter segment. Competitive levers pivot on reimbursement-linked pricing, regulatory approvals that unlock hospital tenders, and distribution depth into pharmacies plus home-care channels; product innovation remains incremental—smaller sample volumes, Bluetooth pairing, app ecosystems—rather than step-change technology.

Global players pursue tuck-in M&A to secure algorithm start-ups and sensor fabs, while local manufacturers counter with cost-down localisation of strips and lancets. Differentiation is increasingly shifting from hardware accuracy to service stickiness—cloud data portals, coaching subscriptions, and pay-as-you-go sensor models—yet margin pressure intensifies as tenders migrate to average-selling-price indexation and new ISO 15197:2022 protocols inflate compliance spend. Supply-chain resilience has become a secondary battleground after pandemic-era shortages of semiconductor wafers and hydrophilic films.

Roche tightens grip on chemist-led markets via bundled strip-to-app contracts

Medtronic plc defends pump share with vertical sensor integration

Abbott scales Freemium CGM model in emerging markets

Ascensia Diabetes Care drives premium positioning for next-gen strip accuracy

Dexcom accelerates pharmacy channel expansion for G-series sensors

ARKRAY Inc focuses on low-cost local manufacturing in APAC

Key Diabetes Care Devices Companies14 items

Roche

Medtronic plc

J&J

Abbott

Ascensia Diabetes Care

Dexcom

ARKRAY Inc

B. Braun

Terumo Corporation

Ypsomed

Sannuo

Sanofi

I-sens

Market Ecosystem

The Diabetes Care Devices ecosystem spans upstream precision component suppliers, midstream device manufacturers and software integrators, and downstream distributors, service providers, and end users. Value is created through miniaturised electrochemical biosensors, algorithmic glucose analytics, and connected data platforms; it is captured by actors that control regulatory clearances, reimbursement listings, and patient data access.

Ecosystem Participants7 items

Biosensor & MEMS component suppliers — provide platinum, carbon and enzyme-coated electrodes

Device OEMs — assemble glucometers, CGM transmitters, insulin pens and pumps

Software & analytics providers — integrate sensing, dosing algorithms and cloud data

Regulatory notified bodies — certify safety, EMC and cybersecurity compliance

Distributors & pharmacy chains — stock, tender and replenish consumables and hardware

After-sales service partners — calibrate, update firmware and replace worn parts

Healthcare payers & patients — select devices based on reimbursement and out-of-pocket limits

Control points sit with regulators that approve clinical accuracy claims and with payers that set formularies; both determine market access. Dependency risks include enzyme supply volatility, FDA/EMA data-privacy audits, and interoperability mandates such as Bluetooth SIG and IEEE 11073. Switching costs are high for pump-CGM integrated systems because of proprietary cannula interfaces and personalised algorithm training, reinforcing lock-in through long-term service contracts and cloud data retention.

Recent Industry Insights

Over the past 18 months, the Diabetes Care Devices industry trends have been reshaped by a surge of cross-industry alliances. Dexcom’s partnership with Welldoc to integrate continuous glucose monitoring (CGM) data into digital coaching platforms signals a pivot toward data-driven behavior change, while Abbott’s tie-up with WeightWatchers targets prediabetic consumers seeking lifestyle-first interventions. On the M&A front, Philips’ acquisition of DiA Imaging Analysis for AI-powered ultrasound bolsters non-invasive glucose estimation R&D, and Medtronic’s purchase of EOFlow positions it to compete head-on with patch-pump specialists in Europe. Product launches reflect user-centric design: Roche’s Accu-Chek Instant strips now ship in 100% paper pouches to meet pending EU packaging regulations, and Tandem’s Mobi pump—no larger than a credit card—secured FDA clearance for 7-day wear, capitalizing on micro-delivery technology. Regulatory momentum is equally transformative; the FDA’s draft guidance on interoperable CGM classifiers anticipates a 2025 de-novo pathway, encouraging start-ups to embed cybersecurity benchmarks early. Enterprise buyers are shifting procurement to risk-based contracts that reward time-in-range improvements, evidenced by Kaiser Permanente’s 2024 tender tying CGM reimbursements to 5% TIR uplift metrics. Meanwhile, venture funding remains hot: Korean smart-lens company Medi-Insight closed a $42 m Series B to embed fluorescence glucose sensors within silicone-hydrogel contacts, and Berlin’s Pendulum Therapeutics expanded manufacturing capacity after a $30 m raise for its CGM-linked synbiotic supplement. Collectively, these moves forecast a market moving from device-centric to ecosystem-centric care within the next 24 months.

Analyst Overview

The Diabetes Care Devices market outlook remains highly attractive, underpinned by a global patient pool expanding at 6 % CAGR and reimbursement shifts favoring value-based chronic care. Competitive intensity is moderating as sensor-integrated pumps and disposable CGMs raise entry barriers, letting top-four players consolidate 58 % share while regional disrupters capture telehealth niches.

Long-term, demand will outstrip supply of next-gen biosensors through 2028, creating procurement leverage for manufacturers that secure semiconductor and membrane capacity early. Innovation is pivoting from incremental accuracy gains to closed-loop ecosystems that marry AI-driven insulin titration with digital therapeutics, opening new reimbursement codes and recurring SaaS revenue.

Key risks include regulatory tightening on cybersecurity, potential lithium-cell shortages, and pricing pressure as CMS negotiates CGM coverage. Strategics should prioritize resilient supply chains, data-security compliance, and evidence generation demonstrating lower hospitalization rates to sustain premium pricing.

11 items

1. Executive Summary

2. Diabetes Care Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Diabetes Care Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Diabetes Care Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medical Care

6.1.2. Personal Care

6.2. Global Diabetes Care Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Blood Glucose Meters

6.2.2. Blood Glucose Test Strips

6.2.3. Insulin Pumps

6.2.4. Insulin Syringes

6.2.5. Others

6.3. Global Diabetes Care Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Diabetes Care Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Diabetes Care Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Diabetes Care Devices Market Competition by Key Manufacturers

8.1. Global Diabetes Care Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Diabetes Care Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Roche

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Medtronic plc

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. J&J

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbott

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Ascensia Diabetes Care

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. BD

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Dexcom

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. ARKRAY Inc

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. B. Braun

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Terumo Corporation

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Ypsomed

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Sannuo

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Sanofi

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. I-sens

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Diabetes Care Devices Market

Figure 4: Global Diabetes Care Devices Market: Drivers

Figure 5: Global Diabetes Care Devices Market: Challenges

Figure 6: Global Diabetes Care Devices Market: Trends

Figure 7: Global Diabetes Care Devices Market: Opportunity

Figure 8: Global Diabetes Care Devices Market: Restraint

Figure 9: Global Diabetes Care Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Diabetes Care Devices Market Value (USD Million) By Region

Figure 15: Global Diabetes Care Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Diabetes Care Devices Market Value (USD Million) By Region

Figure 23: Global Diabetes Care Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Diabetes Care Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Diabetes Care Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Diabetes Care Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Diabetes Care Devices Market Value (USD Million) By Region

Table 10: Global Diabetes Care Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Diabetes Care Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Diabetes Care Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Diabetes Care Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Roche Basic Information And Sales Area

Table 31: Roche. Products Portfolio

Table 32: Medtronic plc Basic Information And Sales Area

Table 33: Medtronic plc. Products Portfolio

Table 34: J&J Basic Information And Sales Area

Table 35: J&J. Products Portfolio

Table 36: Abbott Basic Information And Sales Area

Table 37: Abbott. Products Portfolio

Table 38: Ascensia Diabetes Care Basic Information And Sales Area

Table 39: Ascensia Diabetes Care. Products Portfolio

Table 40: BD Basic Information And Sales Area

Table 41: BD. Products Portfolio

Table 42: Dexcom Basic Information And Sales Area

Table 43: Dexcom. Products Portfolio

Table 44: ARKRAY Inc Basic Information And Sales Area

Table 45: ARKRAY Inc. Products Portfolio

Table 46: B. Braun Basic Information And Sales Area

Table 47: B. Braun. Products Portfolio

Table 48: Terumo Corporation Basic Information And Sales Area

Table 49: Terumo Corporation. Products Portfolio

Table 50: Ypsomed Basic Information And Sales Area

Table 51: Ypsomed. Products Portfolio

Table 52: Sannuo Basic Information And Sales Area

Table 53: Sannuo. Products Portfolio

Table 54: Sanofi Basic Information And Sales Area

Table 55: Sanofi. Products Portfolio

Table 56: I-sens Basic Information And Sales Area

Table 57: I-sens. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Diabetes Care Devices Market Value (USD Million) By Region

Table 63: Global Diabetes Care Devices Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

FAQs

1. What is the current global Diabetes Care Devices market size?

The global Diabetes Care Devices market size surpassed USD 28 billion in 2023, driven by surging type 2 prevalence and rapid adoption of continuous glucose monitors across major healthcare systems.

2. What is the forecasted growth rate to 2030?

Analysts project a 9-10% CAGR through 2030, pushing the market past USD 50 billion as insulin delivery systems and CGMs become standard chronic-care tools worldwide.

3. What are the primary growth drivers?

Key drivers include rising global diabetes prevalence, shift toward value-based care, reimbursement expansion for CGMs, and increasing user preference for less-invasive, smartphone-integrated devices.

4. What challenges restrain market expansion?

High device cost, intermittent supply-chain shortages, stringent regulatory timelines, data-security concerns, and limited patient literacy in low-income regions collectively temper faster adoption.

5. Which region leads market share?

North America holds ~45% share, propelled by favorable reimbursement, high patient awareness, and strong presence of Dexcom, Abbott, and Medtronic R&D hubs.

6. Who are the top companies to watch?

Dexcom, Abbott, Roche, Medtronic, and Insulet dominate pipelines, while emerging players like Senseonics, EOFlow, and Ypsomed accelerate next-gen patch pumps and implantable sensors.

7. Where are the biggest future opportunities?

Closed-loop artificial pancreas systems, disposable patch pumps in emerging markets, and software-centric digital therapeutics offering personalized dosing analytics represent high-growth white spaces.

8. How is technology reshaping competition?

AI-driven predictive glucose alerts, cloud-based data sharing, 3-D printed microneedles, and smartphone ecosystems are lowering entry barriers and shifting differentiation toward algorithm accuracy.

9. What does the evolving regulatory landscape look like?

FDA is fast-tracking interoperable CGMs under class II software-as-medical-device pathways, while EU MDR emphasizes post-market surveillance, cybersecurity, and clinical evidence for insulin pumps.

10. How will pricing pressures affect the future outlook?

Payers are piloting value-based procurement, pushing vendors toward modular, lower-cost platforms; companies that bundle hardware with data analytics are best positioned to maintain margin.

Contact for Full Report

Loading report content...

Diabetes Care Devices Growth, Trends & Forecast Outlook 2033

Market Snapshot

Diabetes Care Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Diabetes Care Devices Segmentation

Diabetes Care Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current global Diabetes Care Devices market size?

2. What is the forecasted growth rate to 2030?

3. What are the primary growth drivers?

4. What challenges restrain market expansion?

5. Which region leads market share?

6. Who are the top companies to watch?

7. Where are the biggest future opportunities?

8. How is technology reshaping competition?

9. What does the evolving regulatory landscape look like?

10. How will pricing pressures affect the future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Diabetes Care Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Diabetes Care Devices Segmentation

Diabetes Care Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current global Diabetes Care Devices market size?

2. What is the forecasted growth rate to 2030?

3. What are the primary growth drivers?

4. What challenges restrain market expansion?

5. Which region leads market share?

6. Who are the top companies to watch?

7. Where are the biggest future opportunities?

8. How is technology reshaping competition?

9. What does the evolving regulatory landscape look like?

10. How will pricing pressures affect the future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation